Therapeutic Potential of In Vitro-Derived Oocytes for the Restoration and Treatment of Female Fertility

Annu Rev Anim Biosci. 2022 Feb 15:10:281-301. doi: 10.1146/annurev-animal-020420-030319. Epub 2021 Nov 29.

Abstract

Considerable progress has been made with the development of culture systems for the in vitro growth and maturation (IVGM) of oocytes from the earliest-staged primordial follicles and from the more advanced secondary follicles in rodents, ruminants, nonhuman primates, and humans. Successful oocyte production in vitro depends on the development of a dynamic culture strategy that replicates the follicular microenvironment required for oocyte activation and to support oocyte growth and maturation in vivo while enabling the coordinated and timely acquisition of oocyte developmental competence. Significant heterogeneity exists between the culture protocols used for different stages of follicle development and for different species. To date, the fertile potential of IVGM oocytes derived from primordial follicles has been realized only in mice. Although many technical challenges remain, significant advances have been made, and there is an increasing consensus that complete IVGM will require a dynamic, multiphase culture approach. The production of healthy offspring from in vitro-produced oocytes in a secondary large animal species is a vital next step before IVGM can be tested for therapeutic use in humans.

Keywords: follicle; follicle culture; in vitro growth; oocyte; ovary.

Publication types

  • Review

MeSH terms

  • Animals
  • Female
  • Fertility
  • Mice
  • Oocytes*
  • Oogenesis / physiology
  • Ovarian Follicle* / physiology